VY-AADC01: Interim Phase Ib data

Interim data from 10 patients with advanced PD in cohorts 1 and 2 of an open-label, dose-escalation, U.S. Phase Ib trial showed that neurosurgical infusion of 7.5x10 11 vector genomes (vg) and 1.5x10 ...